Targeted drug repurposing in medication-related osteonecrosis of the jaw: a review of teriparatide and pentoxifylline/α-tocopherol protocols. [PDF]
Huang W, Chen J, Zhou Q, Rezaei A.
europepmc +1 more source
The Efficacy of a Combined Medical and Surgical Protocol in the Management of Medication-Related Osteonecrosis of the Jaw: A Retrospective Study. [PDF]
Deshpande DR +5 more
europepmc +1 more source
Medication-related osteonecrosis of the jaw in patient with McCune-Albright syndrome: A rare case report. [PDF]
Milani CM +4 more
europepmc +1 more source
Harmonized quantitative bone SPECT/CT parameters for risk assessment of medication-related osteonecrosis of the jaw: multicenter study. [PDF]
Kitajima K +10 more
europepmc +1 more source
Effect of hyaluronic acid on the prevention of medication-related osteonecrosis of the jaw in a bisphosphonate-treated rat model. [PDF]
Gachayev K +5 more
europepmc +1 more source
Management of severe bone loss in patients at risk of medication-related osteonecrosis of the jaw with microsurgery and guided bone regeneration: A case study. [PDF]
Ferreira PF +3 more
europepmc +1 more source
Stage-related changes of bone density and volume in treatment of medication-related osteonecrosis of the jaw. [PDF]
Nguyen QH, Nguyen H, Giap HV, Lee JK.
europepmc +1 more source
Endodontic Consequences of Early Stage of Medication-Related Osteonecrosis of the Jaw: A Case Report. [PDF]
Baaroun V +7 more
europepmc +1 more source
Molecular Basis of Surfactin-Induced Macrophage Modulation and Its Implications in Medication-Related Osteonecrosis of the Jaw Pathogenesis. [PDF]
Kodama-Maruyama Y +7 more
europepmc +1 more source
Related searches:

